Analabs Resources Bhd (7083) - Total Liabilities
Based on the latest financial reports, Analabs Resources Bhd (7083) has total liabilities worth RM305.62 Million MYR (≈ $76.73 Million USD) as of October 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Analabs Resources Bhd - Total Liabilities Trend (2013–2025)
This chart illustrates how Analabs Resources Bhd's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Analabs Resources Bhd to evaluate short-term liquidity relative to the company's equity base.
Analabs Resources Bhd Competitors by Total Liabilities
The table below lists competitors of Analabs Resources Bhd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Victory Square Technologies Inc
F:6F6
|
Germany | €8.17 Million |
|
Moneyme Ltd
AU:MME
|
Australia | AU$1.79 Billion |
|
Do Day Dream Public Company Limited
BK:DDD
|
Thailand | ฿309.00 Million |
|
Intervacc AB
ST:IVACC
|
Sweden | Skr18.76 Million |
|
Shree Rama Newsprint Limited
NSE:RAMANEWS
|
India | Rs5.47 Billion |
|
Lay Hong Bhd
KLSE:9385
|
Malaysia | RM449.20 Million |
|
Penguen Gida Sanayi AS
IS:PENGD
|
Turkey | TL2.54 Billion |
|
Nuveen New York Select Tax-Free Income Portfolio
NYSE:NXN
|
USA | $658.55K |
Liability Composition Analysis (2013–2025)
This chart breaks down Analabs Resources Bhd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 7083 stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.28 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.10 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.62 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Analabs Resources Bhd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Analabs Resources Bhd (2013–2025)
The table below shows the annual total liabilities of Analabs Resources Bhd from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-04-30 | RM279.06 Million ≈ $70.06 Million |
+29.41% |
| 2024-04-30 | RM215.65 Million ≈ $54.14 Million |
+26.10% |
| 2023-04-30 | RM171.01 Million ≈ $42.93 Million |
+39.25% |
| 2022-04-30 | RM122.81 Million ≈ $30.83 Million |
+2.39% |
| 2021-04-30 | RM119.94 Million ≈ $30.11 Million |
+19.09% |
| 2020-04-30 | RM100.71 Million ≈ $25.28 Million |
+35.94% |
| 2019-04-30 | RM74.08 Million ≈ $18.60 Million |
+20.29% |
| 2018-04-30 | RM61.59 Million ≈ $15.46 Million |
+3.42% |
| 2017-04-30 | RM59.55 Million ≈ $14.95 Million |
-8.38% |
| 2016-04-30 | RM65.00 Million ≈ $16.32 Million |
-13.33% |
| 2015-04-30 | RM75.00 Million ≈ $18.83 Million |
+1.35% |
| 2014-04-30 | RM74.00 Million ≈ $18.58 Million |
+80.49% |
| 2013-04-30 | RM41.00 Million ≈ $10.29 Million |
-- |
About Analabs Resources Bhd
Analabs Resources Berhad, an investment holding company, manufactures, formulates, and sells resins, chemicals, and building materials in Malaysia, rest of Asia, and internationally. The company operates through six segments: Asset and Portfolio Management; Manufacturing, Formulation and Sale of Resin, Chemicals and Building Materials; Contract Work, Pipe Laying and Rehabilitation; Investment Hol… Read more